Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Hedge Funds Are Betting Big On These Sliding Stocks

Page 1 of 2

The majority of 13F filings for the latest reporting period have been processed by the Insider Monkey team, giving us access to a treasure trove of data on the collective activity of the best money managers in the world. We’ll be producing dozens of reports in the coming days on all sorts of trends taking place among the smart money we track, including their industry-specific investment habits. In this article, we want to start by looking at five stocks that had the confidence of the smart money in the second quarter, but that have been sinking of late. These stocks are Monsanto Company (NYSE:MON), JD.Com Inc (ADR) (NASDAQ:JD), Kinder Morgan (NYSE:KMI), CSX Corporation (NYSE:CSX), and Mosaic Co (NYSE:MOS). Let’s take a look at the action on these stocks and whether they could make for good buy-low candidates.


Why are we interested in the 13F filings of a select group of hedge funds? We use these filings to determine the top 15 small-cap stocks held by these elite funds based on 16 years of research that showed their top small-cap picks are much more profitable than both their large-cap stocks and the broader market as a whole; yet investors have been stuck (until now) investing in all of a hedge fund’s stocks: the good, the bad, and the ugly. Why pay fees to invest in both the best and worst ideas of a particular hedge fund when you can simply mimic the best ideas of the best fund managers on your own? These top small-cap stocks beat the S&P 500 Total Return Index by an average of nearly one percentage point per month in our backtests, which were conducted over the period of 1999 to 2012. Even better, since the beginning of forward testing at the end of August 2012, the strategy worked just as our research predicted and then some, outperforming the market every year and returning 118% over the last 35 months, which is more than 60 percentage points higher than the returns of the S&P 500 ETF (SPY) (see more details).

Let’s start with Monsanto Company (NYSE:MON), in which fund ownership among those we track increased by 10 to 64 during the second quarter, while the aggregate value of their investments climbed by just under $500 million to $3.54 billion on June 30. The increase in holdings is especially notably given that Monsanto had already begun to sink in the second quarter, dipping by more than 5%. That slide has continued into the third quarter, with Monsanto shedding another 3% of its value. Some of the bullish investors of Monsanto Company (NYSE:MON) include Ray Dalio, who added 85,500 shares to his holding in the second quarter, with Monsanto being one of his top positions. Larry Robbins’ Glenview Capital added over 1.38 million shares to its own position, lifting it above the 11.07 million-share mark.

Next up is JD.Com Inc (ADR) (NASDAQ:JD), which has suffered of late under the crushing force of the Chinese stock market collapse. 75 hedge funds we track held $11.81 billion of the company’s shares on June 30, up from 68 and $8.23 billion respectively three months earlier. After a strong second quarter in which shares gained over 20%, they have since given back all of those gains and more, losing over 17% in the third quarter. Tiger Cub Chase Coleman, a strong supporter of Chinese stocks of late, has been particularly ardent when it comes to JD.Com Inc (ADR) (NASDAQ:JD), adding a gargantuan 49.25 million shares to his position in the second quarter, a position that was already his top pick entering the quarter. Julian Robertson, the Tiger himself, was also a supporter of JD.Com during the quarter, buying 2.71 million shares.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!